Zydus Pharmaceuticals recalls specific Succinylcholine Chloride Injection vials due to failed impurities tests. This medication, used for muscle relaxation during surgery, may contain harmful degradation products that could cause serious injury if used improperly.
“Zydus Succinylcholine Chloride Injection Recall: Impurities Risk Serious Injury.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31843-zydus-succinylcholine-chloride-injection-recall-impurities-risk-serious-injury. Based on FDA recall #D-0623-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0623-2025%22&limit=1).
The FDA announced on August 27, 2025, that Zydus Pharmaceuticals (USA) Inc is voluntarily recalling Succinylcholine Chloride Injection due to failed impurity specifications. The recall affects 270,125 vials distributed in Mississippi, Ohio, Louisiana, and Puerto Rico.
How to tell if you have it
Brand: Zydus Pharmaceuticals
Product: Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL)
According to the FDA, the product contains out-of-specification test results for any individual unknown degradation impurity. The recall is classified as Class II.
Context
GovInfoNow's records show Zydus Pharmaceuticals (USA) Inc has 53 other recalls on record since March 14, 2012. Other recent recalls of similar products include Zydus Mirabegron 25mg Tablets Recall (August 5, 2026), Zydus Erythromycin Tablets Recall (April 29, 2026), and Zydus Recalls Icosapent Ethyl Capsules Due to Defects (March 9, 2026). Other recent recalls of similar products include OneSource Specialty Pharma Methohexital Sodium Recall (June 7, 2026), Lupin Ganirelix Acetate Injection Recall (November 13, 2025), and Sagent Busulfan Injection Recall (May 4, 2026).
How to tell if you have this one
Check for vials with NDC 70710-1377-1 (vial) or NDC 70710-1377-2 (carton). The product was manufactured by Zydus Lifesciences Ltd in India and distributed by Zydus Pharmaceuticals (USA) Inc.
Brand
Zydus Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for NDC numbers 70710-1377-1 (vial) or 70710-1377-2 (carton) on the packaging.
Where it went and when
Where it was distributed
Distributed in 3 states and Puerto Rico.
Listed by the agency
Not listed
FDA distribution: “MS, OH, LA, and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Louisiana, Mississippi, Ohio, Puerto Rico.
Recall timeline
FDA published this recall 21 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0623-2025 (August 27, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0623-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.